Lifescan Corporation

Janssen Biotech, Inc.

Ontrak Systems, Inc.

Other

Lam Research Corporation

Alza Corporation

Cordis Corporation

Lorin Philip Olson

Peter A Krulevitch

Nicholas Foley

Mingqi Zhao

Jingli Wang

Lynn S Ryle

Thomas R Gockel

Brett A Whitelaw

James Glencross

Paul Tashjian

Juergen Pfrang

Vaclav Vojan

Devin McAllister

Michael Ravkin

Joseph Creagan Trautman

Koon-Wah Leong

Maria Teodorczyk

Ernest J Kiser

Vadim V Yuzhakov

Allen House

John J Allen

Paul S Montgomery

Robert Justice Shartle

David P Matzinger

John Timothy Lemke

Christopher Philip Leach

Rochelle Kleinberg

Bruce McKendry

Borzu Sohrab

Harshad Ishwarbhai Patel

Donna L Savage

David Shepherd

Gregory Lewis Bennett

Frank Cichocki

Zara Sieh

Loren Robert Larson

Michael C Ryner

Alan Doop

Colleen Hagen

Juergen E Pfrang

Frank R Cichocki

Leif Bowman

Richard Michael Day

Damian Edward Haydon Baskeyfield

Anne Thomson

Sebastian Bohm

Devin Mcallister

A device configured to administer a medication can comprise a lower housing that includes a housing latch. The device can further comprise a needle guard that is movable relative to the lower housing along a first direction from a first position to a second position so as to expose a needle, and an upper housing supported relative to the lower housing. The upper housing can be configured to move with respect to the lower housing along a second direction from a pre-use position to a dispensed position. The housing latch can releasably interfere with the upper housing when the upper housing is in the pre-use position so as to prevent the upper housing from moving toward the dispensed position, and the movement of the needle guard toward the second position, causes the interference to be removed, thereby allowing the upper housing to move toward the second position.

Palm activated drug delivery device

Portable adjustable book stand

Disclosed is a device for the parenteral delivery of a medication, such as a drug. The device includes upper and lower housings in which the upper housing is configured to move relative to the lower housing as a result of application of an external force to permit the user of the device to control the rate at which the drug is administered.

Disclosed herein is an adjustable stand for supporting objects on the adjustable stand, in accordance with some embodiments. Accordingly, the adjustable stand comprises a bottom plate, a middle plate, a top plate, a toggle mechanism, and an actuating device. The toggle mechanism allows pivoting of the top plate in an unlocked state and restricts the pivoting in the locked state. The actuating device transitions the toggle mechanism to the unlocked state by receiving a first actuating input and transitions the toggle mechanism to the locked state by receiving a second actuating input. The toggle mechanism transitions to the unlocked state from the locked state based on applying a pivoting force on the top plate above a threshold pivoting force without receiving the first actuating input. The toggle mechanism transitions to the locked state from the unlocked state based on releasing the pivoting force applied to the top plate.

Adjustable stand for supporting objects on the adjustable stand

An applicator for applying a microprojection member to the stratum corneum of a patient having a housing, a piston moveable within the housing and a cap adapted to activate the applicator. The applicator is self-setting and auto-triggering, which allows the applicator to be used by patient's having neither the strength, nor the manual dexterity to pre-set and activate other types of applicator devices.

Self-actuating applicator for microprojection array

Drug delivery device

A lancing device includes a lancing mechanism, a floating probe and a pressure tip. The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip of the lancing device is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge. A method for lancing a target site includes providing the lancing device describe above and contacting the pressure tip of the lancing device with the target site. The pressure tip is then urged towards the target site to create a target site bulge with the floating probe of the lancing device floating on a surface of the target site bulge. Next, the target site bulge is lanced while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet.

Lancing device with a floating probe for control of penetration depth

A system employing an integrated analyte test strip including a biosensor and lancet is disclosed. The integration of lancet and the sensor elements eliminates the need to align the sensor to the biologic fluid sample after a lancet and lancing device are used in combination to pierce the skin. The system preferably includes a device comprising two body portions that slide relative to each other to both cock and fire a test strip at a target site. Meter reading and test strip disposal may be accomplished by removing the device from the target site. The device preferably employs a magazine loaded with test strips, with one strip being taken from the magazine each time the device is actuated. It preferably also includes a magazine in a cap to store spent test strips for disposal. The device may be turned on an off simply by removal and return of the cap.

Minimal procedure analyte test system

Methods and devices for electrochemically detecting a change in the viscosity of a fluid are provided. In the subject methods, a fluid sample (e.g., a whole blood sample) is introduced into an electrochemical test strip's electrochemical cell using a micro-needle integrated into one of oppositely spaced apart working and reference electrodes. An electric potential is applied to the electrochemical cell to first achieve a steady state cell current. A decrease in the steady state cell current is then detected and related to a change in viscosity of the sample. In many embodiments, the sample is blood and the change in viscosity is related to the onset of coagulation in the blood sample, and often the PT of the blood sample. An electrochemical test strip includes an electrochemical cell and an integrated micro-needle. The electrochemical cell includes oppositely spaced apart working and reference electrodes and a reagent mixture (e.g., a redox couple and a coagulation catalyzing agent). The micro-needle is integrated into one of the working and reference electrodes of the electrochemical cell.

Electrochemical test strip with an integrated micro-needle and associated methods

Growing community of inventors

Scotts Valley, CA, United States of America

Lorin Philip Olson